Source:http://linkedlifedata.com/resource/pubmed/id/15963110
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-6-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1464-4096
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15963110-Androgen Antagonists,
pubmed-meshheading:15963110-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15963110-Gonadotropin-Releasing Hormone,
pubmed-meshheading:15963110-Humans,
pubmed-meshheading:15963110-Male,
pubmed-meshheading:15963110-Pain,
pubmed-meshheading:15963110-Prostatic Neoplasms
|
pubmed:year |
2005
|
pubmed:articleTitle |
The 'flare' phenomenon: should we be concerned?
|
pubmed:affiliation |
Department of Urology, Bristol Royal Infirmary, Bristol, UK. rthurairaja@doctors.org.uk
|
pubmed:publicationType |
Journal Article
|